Drug intelligence / Profile preview

yohimbe

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Yohimbe is an herbal supplement derived from the bark of the West African evergreen tree Pausinystalia yohimbe[3][4][5]. It has a long-standing traditional use as an aphrodisiac and for the treatment of erectile dysfunction. The active alkaloid in yohimbe bark is yohimbine, which acts primarily as an alpha-2 adrenergic receptor antagonist—blocking inhibitory presynaptic receptors and thereby increasing neurotransmitter release, including norepinephrine[1][6]. This leads to increased sympathetic activity, vasodilation in genital tissues, and effects on mood, anxiety, and sexual arousal[1][6]. Yohimbe is also marketed for weight loss, athletic performance, and as a stimulant, though there is limited clinical evidence for these uses and significant safety concerns exist, especially with variable alkaloid content in supplements[2][3][4][5][7].

Brand names
AphrodienAphrodyneJohimbiYoconYohimbeYohimbehe
Other names
Pausinystalia yohimbeyohimbine (as a constituent)yohimbe bark extract
02

Targets

HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))HTR1B (5-Hydroxytryptamine Receptor 1B)HTR1D (5-hydroxytryptamine receptor 1D)HTR2B (5-Hydroxytryptamine Receptor 2B)KATP channel (ATP-sensitive potassium channel)ADRA2A (α2A)ADRA2B (α2B)ADRA2C (α2C)DRD2 (Dopamine D2 Receptor)DRD3 (Dopamine receptor D3)HTR2A (Serotonin receptor 5-HT2A)HTR2C (5-hydroxytryptamine 2C receptor)DRD (Dopamine receptors)

Beyond the preview

Go deeper on yohimbe.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on yohimbe.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call